Invention Grant
- Patent Title: Peptides for the treatment of covid-19
-
Application No.: US17133035Application Date: 2020-12-23
-
Publication No.: US11339190B2Publication Date: 2022-05-24
- Inventor: Kalipada Pahan
- Applicant: Rush University Medical Center
- Applicant Address: US IL Chicago
- Assignee: Rush University Medical Center
- Current Assignee: Rush University Medical Center
- Current Assignee Address: US IL Chicago
- Agency: Taft Stettinius & Hollister LLP
- Agent Joseph M. Bennett-Paris
- Main IPC: C07K7/06
- IPC: C07K7/06 ; C07K7/08 ; A61K9/00 ; A61P31/14 ; A61K38/10 ; A61K38/08 ; A61K38/00
Abstract:
Compositions for inhibiting the binding between ACE2 and SARS-CoV-2 spike S1 are disclosed. Methods of treating COVID-19 are disclosed. Methods of making an in vivo model of COVID-19 are also disclosed.
Public/Granted literature
- US20210324004A1 Peptides for the Treatment of COVID-19 Public/Granted day:2021-10-21
Information query
